Benoît Guéry - Concepedia

Author

Benoît Guéry

Université de Lille ORCID

Also Known As

Anne Collignon, B GUERY, B Guery, B Guéry, B P Guery, B P H GUERY, B. Guery, B. Guéry, B. P. Guery, B. P. H. Guery

382

Publications

12K

Citations

H-Index

135

Concepts

All Affiliations

Université de Lille Centre Hospitalier Universitaire de Lille University of Lausanne Inserm Centre Hospitalier de Tourcoing

About

Benoît Guéry is an author at Université de Lille specializing in medicine, clinical microbiology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	53	4K
2	Health Sciences	7	7	252
3	Allergy	6	6	224
4	Public Health	3	3	149
5	Biomedical Engineering	1	1	49

Benoît Guéry

113

Publications

Citations

H-Index

Page 1

	Year	Citations
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults Joffrey van Prehn, Elena Reigadas, Erik Vogelzang, Clinical Microbiology and Infection	2021	564
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission Benoît Guéry, Julien Poissy, Loubna El Mansouf, The Lancet Nosocomial TransmissionViral DiagnosisVirus EpidemiologyViral DiagnosticsRespiratory Diseases	2013	423
A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit O. Leroy, Ch. Santré, C. Beuscart, Intensive Care Medicine Critical Care ManagementCritical Care MedicineIntensive Care UnitFive-year StudyAcute Care	1995	315
Role of LecA and LecB Lectins in <i>Pseudomonas aeruginosa</i> -Induced Lung Injury and Effect of Carbohydrate Ligands Chanez Chemani, Anne Imberty, Sophie de Bentzmann, Infection and Immunity	2009	293
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside? Emmanuel Faure, Julien Poissy, Anne Goffard, PLoS ONE Distinct Immune ResponseWorld Health OrganizationViral DiagnosticsImmunodeficienciesImmunology	2014	249
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila, The Lancet Infectious Diseases Patients 60Antimicrobial SusceptibilityAntibioticsClostridium Difficile InfectionAntimicrobial Chemotherapy	2017	208
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013 Alexandra Mailles, K. Blanckaert, P. Chaud, Eurosurveillance	2013	152
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit Nicolas Boussekey, O. Leroy, Hugues Georges, Infection Critical Care ManagementCritical Care MedicineAdmission Procalcitonin LevelsIntensive Care UnitCommunity–acquired Pneumonia	2005	134
Antiadhesive Properties of Glycoclusters against <i>Pseudomonas aeruginosa</i> Lung Infection Amine M. Boukerb, Audric Rousset, Nicolas Galanos, Journal of Medicinal Chemistry AntibioticsAntiadhesive PropertiesMedicinePolymer-drug ConjugateGlycobiology	2014	129

Page 1